Isolindleyin exerts anti-melanogenic effects in human epidermal melanocytes via direct binding to tyrosinase

To overcome dermatological concerns causing abnormally excessive melanin synthesis, highly effective and safe skin depigmentation compounds have been identified in the cosmetic and pharmaceutical industries. Among several methods used to achieve skin depigmentation, inhibition of tyrosinase is one of the most effective, since tyrosinase is a crucial enzyme in melanogenesis. Herein, isolindleyin, a novel inhibitor of human tyrosinase, was introduced and evaluated for its anti-melanogenic effects in human epidermal melanocytes. The results revealed that isolindleyin was directly bound to tyrosinase and it suppressed melanin synthesis. The binding mode between isolindleyin and the active sites of human tyrosinase was investigated using computational molecular docking at the atomic level. Isolindleyin binding was found to be stabilized by hydrophobic interactions between His 367 and Val 377 and by hydrogen bonds between Ser 380 and Asn 364. The results of this study revealed the anti-melanogenic effects of isolindleyin that could contribute toward overcoming dermatological concerns that cause abnormally excessive melanin synthesis. (C) 2020 Published by Elsevier Inc.

Automated summary

Effective and safe skin depigmentation compounds have been identified in the cosmetic and pharmaceutical industries, with inhibition of tyrosinase being one of the most effective methods. Isolindleyin, a novel tyrosinase inhibitor, was found to suppress melanin synthesis by directly binding to tyrosinase and stabilizing the binding through hydrophobic interactions and hydrogen bonds at the active sites. This study highlights the anti-melanogenic effects of isolindleyin in overcoming dermatological concerns related to abnormal melanin synthesis.